Stocktoria
Alzamend Neuro, Inc. ALZN
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-06-15
Alzamend Neuro, Inc. statistics & valuation
Market cap$4.6M
P / B1.2×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -98.1% | -1575.0% | -251.5% | -85.2% | -173.3% |
| Return on equity | -113.8% | 383.5% | -488.5% | -92.6% | -250.7% |
| Current ratio | — | — | 2.03 | 12.37 | 3.24 |
Source: SEC EDGAR filings · CIK 0001677077 · as of 2025-04-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.